Services
HHML
HEART & Heart Medical Laboratories
No. 267, Wenxue Road, Zuoying District, Kaohsiung City 813
(07) 972-1699 Ext. 178
L5% & ASCVD Risk
L5% and the Risk of Atherosclerotic Cardiovascular Disease
L5 is the most electronegative and harmful subclass of LDL.
With our patented technology, we can accurately analyze the percentage of L5 in LDL (L5%).
In individuals with LDL-C ≦ 190 mg/dL and without a history of cardiovascular disease or diabetes, an L5% value of < 2% indicates a low risk.
It is recommended to reassess the patient's overall risk factors and provide appropriate diagnostic tests and treatment as needed.
Advanced diagnostic tests, such as treadmill testing, stress echocardiography, and, if necessary, coronary angiography are recommended.
Timely implementation of advanced diagnostic and treatment measures is recommended.
Urgent treatment is recommended.
L5, an electronegative lipoprotein, a subgroup of low-density lipoprotein (LDL), is considered the real "bad cholesterol." While normal LDL can be broken down and utilized by cells, the harmful lipids carried by L5 trigger inflammatory responses in blood vessels, leading to damage to endothelial cells. These damaged signals attract macrophages, forming plaques that accumulate within the vessel walls. Furthermore, the signals from the damage can also cause platelet aggregation, forming blood clots that block blood flow, reducing blood supply. If this occurs in the coronary arteries of the heart, it can result in a heart attack; if it occurs in cerebral blood vessels, it can lead to a stroke.
Services
Services
Examination Fee
-
Advanced Cardiovascular Risk Assays
-
▸Set A: 36 Biochemical Blood Test Parameters + L5% NT 4500
-
▸Set B: 36 Biochemical Blood Test Parameters + L5%+H5% NT 6500
-
▸Set C: 36 Biochemical Blood Test Parameters+H5% NT 4500
-
Electronegative lipoprotein relative quantification analysis (L5%+H5%) NT 6000
-
Electronegative low-density lipoprotein relative quantification analysis (L5%) NT 4000
-
Electronegative high-density lipoprotein relative quantification analysis (H5%) NT 4000
-
家族性高膽固醇血症基因檢測 NT 15000
36 Biochemical Blood Test Parameters
36 Biochemical Blood Test Parameters
✦高敏度C反應球蛋白 hsCRP
✦總膽固醇 Total Cholesterol
✦三酸甘油脂(需空腹) Triglyceride (TG)
✦高密度脂蛋白膽固醇 HDL-Cholesterol
✦低密度脂蛋白膽固醇 LDL-Cholesterol
✦極低密度脂蛋白膽固醇(需空腹) VLDL-Cholesterol
✦動脈硬化指數 T-Cho/HDL-Cho
✦脂蛋白a Lipoprotein a, Lp(a)
✦糖化血色素 HbA1c
✦麩胺酸苯醋酸轉氨基酶 GOT (AST)
✦麩胺酸丙酮酸轉氨基酶 GPT (ALT)
✦鹼性磷酯酶 Alk-P
✦總蛋白 Total Protein
✦白蛋白 Albumin
✦球蛋白 Globulin
✦白蛋白/球蛋白比值 A/G Ratio
✦總膽紅素 Total Bilirubin
✦直接膽紅素 Direct Bilirubin
✦麩胺轉酸酶 ƴ-GT
✦血清尿素氮 BUN
✦肌酸酐 Creatinine
✦尿酸 Uric Acid
✦腎絲球過濾率 eGFR
✦白血球 WBC
✦紅血球 RBC
✦血色素 Hemoglobin (Hb)
✦血球比容值測定 Hematocrit (Ht)
✦平均紅血球容積 MCV
✦平均紅血球血紅素量 MCH
✦平均紅血球血紅素濃度 MCHC
✦血小板 Platelet
✦嗜中性球Neutrophils
✦ 淋巴球 Lymphocytes
✦單核球 Monocytes
✦嗜酸性球 Eosinophils
✦嗜鹼性球 Basophils
Citation
[1] Chen, CH. et al. Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription. Circulation. 2003 ;107: 2102–2108.
[2] Chan, HC. et al. Highly electronegative LDL from patients with ST-elevation myocardial infarction triggers platelet activation and aggregation. Blood. 2013;122(22):3632-41.
[3] Shen, MY. et al. Plasma L5 levels are elevated in ischemic stroke patients and enhance platelet activation and aggregation. Blood. 2016;127:1336-45.
[4] Chu, CS. et al. Range of L5 LDL levels in healthy adults and L5’s predictive power in patients with hyperlipidemia or coronary artery disease. Sci Rep. 2018;8(1):11866.
[5] Kraler, S. et al. SPUM-ACS investigators. Low-density lipoprotein electronegativity and risk of death after acute coronary syndromes: A case-cohort analysis. Atherosclerosis. 2023;376:43-52.